Clinical Trials

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04953312 2026-03-12

CALPRO

Phase NA Withdrawn

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT06510868 2026-03-05

MDS & PRRT

Recruiting

45 enrolled

Phase 1/2 Active not recruiting

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

Enrolling by invitation

5,000 enrolled

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

43 enrolled

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05983991 2025-12-26

GATA-2

Phase NA Recruiting

150 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05735704 2025-03-26

SANGUINE

LymphoidMyeloidOther hematologic neoplasmPlasma cell

3,000 enrolled

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms

NCT05839717 2024-12-17

CLOJAK

Recruiting

120 enrolled

Myeloproliferative Disorders, Thrombosis

NCT06130787 2024-09-27

BIO-TIMER

Phase NA Recruiting

321 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03003325 2024-09-19

Low-PV

Phase 2 Completed

127 enrolled

Polycythemia Vera

NCT03259230 2024-09-19

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

40 enrolled 43 charts

Lymphohistiocytosis, Hemophagocytic

NCT01904136 2024-01-24

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Phase 1/2 Completed

54 enrolled 18 charts

Blast Crisis, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute

NCT06177366 2023-12-20

FIBROMOELLE

120 enrolled

Myeloproliferative Disorders

NCT05714592 2023-02-22

MYELOCARTOCH

Phase NA Unknown

300 enrolled

Myeloproliferative Disorders

NCT02761473 2020-08-20

Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations

50 enrolled

DermatologicMyeloid

Urticaria Pigmentosa, Mastocytosis, Cutaneous

NCT02862366 2018-10-31

MICROP-SMP

128 enrolled

Myeloproliferative Disorders

NCT01970930 2018-01-19

Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients

131 enrolled

LymphoidMyeloidOther hematologic neoplasm

Polycythemia Vera, Thrombocythemia, Essential

NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Phase 1 Completed

33 enrolled

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02883036 2016-08-30

Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia

100 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01284712 2015-10-01

Natural Killer Cells and Polycythemia Vera (Vaquez's Disease)

27 enrolled

Polycythemia Vera

NCT02489929 2015-07-03

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Phase NA Unknown

35 enrolled

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT02016833 2015-04-30

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity